MedTrace Logo

Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients

NCT02576197 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2016-10-18

No results posted yet for this study

Summary

This study evaluates the efficiency of a probiotic as a coadjuvant in the conventional treatment of mild to moderate plaque psoriasis. Half of the patients will receive the probiotic per os, while the other half will receive a placebo; all patients will continue with their regular psoriasis treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

one capsule per day, containing the probiotic along with the patient's customary psoriasis treatment (excluding systemic treatments)

DIETARY_SUPPLEMENT

Placebo

one capsule per day, containing the placebo, along with the patient's customary psoriasis treatment (excluding systemic treatments)

Sponsors & Collaborators

  • Korott, S.L.

    collaborator INDUSTRY

  • Biopolis S.L.

    lead INDUSTRY

Principal Investigators

  • Vicente Navarro-López, MD · Universidad Católica San Antonio de Murcia

  • Ana A Ramirez-Boscá, MD · Universidad Católica San Antonio de Murcia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576197 on ClinicalTrials.gov